AI-generated from publicly available materials.Leipzig's JawBuddy has successfully secured €818k in pre-Seed funding to advance its innovative approach to alleviating jaw pain, bruxism, and TMJ-related tension.
The funding round was led by HALBZEIT, a healthcare platform, and included contributions from notable figures in dentistry such as Dr. Siegfried Marquardt and Dr. Guido Sigron, along with various investors and business angels. This financial boost is intended to facilitate the startup's clinical trials and pave the way for reimbursement processes, as highlighted by co-founder and CEO Leon Rauch, who emphasized the gap in care between dental appointments.
Founded in 2025, JawBuddy combines digital health solutions with clinical backing to offer personalized self-therapy programs designed by physiotherapists. The app not only guides users through tailored exercises but also utilizes smartphone technology to monitor progress. This innovative approach aims to address the root causes of jaw-related issues and enhance patient outcomes through evidence-based practices.
As JawBuddy prepares for its clinical pilot projects and a multicenter randomized controlled trial set for late 2026, the company is also in discussions for a care contract with a major health insurer. This strategic positioning could significantly impact the landscape of dental care, particularly in addressing the recurring issue of patients with jaw disorders, as noted by HALBZEIT's Luisa Wasilewski.